Literature DB >> 11262943

Maximum likelihood analysis of adaptive evolution in HIV-1 gp120 env gene.

Z Yang1.   

Abstract

Every functional protein appears to have some conserved amino acids which are critically important to the basic structure and function of the protein and thus under purifying selection. Some proteins also have variable amino acids which, when changed, offer a selective advantage, and thus undergo adaptive evolution. These amino acids are also important to the structure and function of the protein, although in a different way. It seems that the selective pressure in every protein varies among sites. Maximum likelihood models developed recently for comparison of silent and replacement nucleotide substitution rates allow for variable selective pressures among amino acid sites, and provide a powerful approach to studying the evolutionary process of protein-coding genes. This paper applies the likelihood models to analyze a data set of 186 HIV-1 gp120 env gene sequences for comparison with a previous analysis of the same data set. The maximum likelihood analysis identified a number of sites under positive selection, some in the conserved regions of the protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11262943

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  14 in total

1.  Adaptive evolution of MRG, a neuron-specific gene family implicated in nociception.

Authors:  Sun Shim Choi; Bruce T Lahn
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

2.  Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites.

Authors:  Maria Anisimova; Rasmus Nielsen; Ziheng Yang
Journal:  Genetics       Date:  2003-07       Impact factor: 4.562

3.  Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes.

Authors:  Simon A A Travers; Mary J O'Connell; Grace P McCormack; James O McInerney
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Molecular evolution of the hepatitis delta virus antigen gene: recombination or positive selection?

Authors:  Maria Anisimova; Ziheng Yang
Journal:  J Mol Evol       Date:  2004-12       Impact factor: 2.395

5.  Bursts of nonsynonymous substitutions in HIV-1 evolution reveal instances of positive selection at conservative protein sites.

Authors:  Georgii A Bazykin; Jonathan Dushoff; Simon A Levin; Alexey S Kondrashov
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-12       Impact factor: 11.205

6.  Evidence of positive Darwinian selection in putative meningococcal vaccine antigens.

Authors:  David A Fitzpatrick; Christopher J Creevey; James O McInerney
Journal:  J Mol Evol       Date:  2005-06-29       Impact factor: 2.395

7.  Widespread adaptive evolution in the human immunodeficiency virus type 1 genome.

Authors:  Wa Yang; Joseph P Bielawski; Ziheng Yang
Journal:  J Mol Evol       Date:  2003-08       Impact factor: 2.395

8.  Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?

Authors:  Tulio de Oliveira; Marco Salemi; Michelle Gordon; Anne-Mieke Vandamme; Estrelita Janse van Rensburg; Susan Engelbrecht; Hoosen M Coovadia; Sharon Cassol
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

9.  Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects.

Authors:  Filippo Canducci; Maria Chiara Marinozzi; Michela Sampaolo; Stefano Berrè; Patrizia Bagnarelli; Massimo Degano; Giulia Gallotta; Benedetta Mazzi; Philippe Lemey; Roberto Burioni; Massimo Clementi
Journal:  Retrovirology       Date:  2009-01-15       Impact factor: 4.602

10.  Divergent evolution and purifying selection of the flaA gene sequences in Aeromonas.

Authors:  Maribel Farfán; David Miñana-Galbis; M Carmen Fusté; J Gaspar Lorén
Journal:  Biol Direct       Date:  2009-07-21       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.